XML 38 R22.htm IDEA: XBRL DOCUMENT v2.4.0.6
Equity Compensation (Tables)
6 Months Ended
Jun. 30, 2012
Stock-Based Compensation Expense and Related Income Tax Benefit

The stock-based compensation expense and related income tax benefit recognized in our Condensed Consolidated Statements of Income in the periods indicated were as follows:

 

     Three Months Ended
June 30,
    Six Months Ended
June 30,
 
     2012     2011     2012     2011  

Stock-based compensation expense

   $ 4,272      $ 4,758      $ 8,755      $ 8,672   

Income tax (benefit)

   ($ 1,645   ($ 1,832   ($ 3,371   ($ 3,339
Stock Options Granted, Forfeited, Exercised and Expired

The stock options granted, forfeited, exercised and expired in the period indicated were as follows:

 

     Six Months Ended June 30, 2012  
     # of
Shares
    Weighted
Average
Exercise
Price
     Aggregate
Exercise
Price
    Weighted
Average
Remaining
Contractual Term
     Aggregate
Intrinsic
Value (1)
 

Outstanding at beginning of period

     1,765,881      $ 79.24       $ 139,922        

Granted

     156,500      $ 75.16         11,763        

Forfeited

     (6,667   $ 90.45         (603     

Exercised

     (197,965   $ 40.87         (8,091     

Expired

     (1,734   $ 17.25         (30     
  

 

 

      

 

 

      

Outstanding at end of period

     1,716,015      $ 83.31       $ 142,961        3.5       $ 5,875   
  

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Exercisable at end of period

     1,358,175      $ 83.12       $ 112,887        2.9       $ 5,875   
  

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

 

(1) The aggregate intrinsic value of the stock options was calculated by identifying those stock options that had a lower exercise price than the closing market price of our common stock on June 29, 2012 and multiplying the difference between the closing market price of our common stock and the exercise price of each of those stock options by the number of shares subject to those stock options that were outstanding or exercisable, as applicable.
Stock Options Granted and Exercised

The following table sets forth information regarding the stock options granted and exercised in the periods indicated:

 

     Three Months Ended
June 30,
     Six Months Ended
June 30,
 
     2012      2011      2012      2011  

Shares subject to stock options granted

     0         0         156,500         159,500   

Weighted average grant date fair value per share

   $ 0       $ 0       $ 31.36       $ 28.90   

Shares subject to stock options exercised

     93,911         42,780         197,965         103,310   

Intrinsic value of stock options exercised

   $ 2,299       $ 1,659       $ 4,788       $ 2,570   

Proceeds received from stock options exercised

   $ 3,423       $ 1,955       $ 8,091       $ 4,983   

Tax benefits realized from stock options exercised

   $ 733       $ 638       $ 1,597       $ 989   
Estimated Fair Value of Stock Option Grant

The fair value of each stock option grant was estimated on the date of grant using the following assumptions:

 

     Three Months
Ended June 30,
   Six Months
Ended June 30,
 
     2012      2011    2012     2011  

Risk-free interest rates

     Not applicable       Not applicable      0.7     1.8

Expected lives (in years)

     Not applicable       Not applicable      4.5        4.7   

Volatility

     Not applicable       Not applicable      51     48

Dividend yield

     Not applicable       Not applicable      None        None   
Number of Restricted Stock Units (RSUs) Granted, Forfeited and Vested

The following table sets forth the number of restricted stock units (“RSUs”) that were granted, forfeited and vested in the period indicated:

 

     Six Months Ended
June 30, 2012
 
     # of RSUs     Weighted
Average Grant
Date
Fair Value
 

Unvested at beginning of period

     314,006      $ 79.44   

Granted

     272,578      $ 74.20   

Forfeited

     (30,397   $ 75.05   

Vested

     (117,038   $ 82.59   
  

 

 

   

Unvested at end of period

     439,149      $ 75.65